Nutex Health Inc
$ 101.05
-4.40%
10 Apr - close price
- Market Cap 747,502,000 USD
- Current Price $ 101.05
- High / Low $ 106.62 / 100.50
- Stock P/E 10.09
- Book Value 46.49
- EPS 10.48
- Next Earning Report 2026-05-12
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.31 %
- ROE 0.59 %
- 52 Week High 193.07
- 52 Week Low 77.21
About
Nutex Health, Inc. is a technology-based healthcare services company. The company is headquartered in Houston, Texas.
Analyst Target Price
$221.67
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-06 | 2025-11-18 | 2025-06-30 | 2025-05-06 | 2025-03-26 | 2024-11-07 | 2024-08-08 | 2024-05-08 | 2024-03-28 | 2023-11-09 | 2023-08-09 | 2023-05-15 |
| Reported EPS | 1.62 | -2.95 | 5.2262 | 11.12 | 11.12 | -1.72 | -0.07 | -0.06 | -0.0467 | -0.01 | -0.01 | -0.01 |
| Estimated EPS | 5.5567 | 1.95 | -5.43 | 3.905 | -0.1233 | -0.24 | -0.29 | None | -0.005 | -0.005 | -0.01 | -0.01 |
| Surprise | -3.9367 | -4.9 | 10.6562 | 7.215 | 11.2433 | -1.48 | 0.22 | 0 | -0.0417 | -0.005 | 0 | 0 |
| Surprise Percentage | -70.846% | -251.2821% | 196.2468% | 184.7631% | 9118.6537% | -616.6667% | 75.8621% | None% | -834% | -100% | 0% | 0% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-12 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: NUTX
2026-04-10 20:39:21
Nutex Health Inc.'s CEO, Thomas T. Vo, expanded his holdings through two significant transactions. An entity he controls received 184,071 shares in a private issuance related to hospital transfers, bringing his indirect ownership to over 2 million shares. Additionally, Vo exercised 4,841 restricted stock units (RSUs) into common shares at no cost, further increasing his direct holdings.
2026-04-05 02:20:00
This article from Stock Traders Daily discusses AI-generated quant signals for Nutex Health Inc. (NASDAQ: NUTX). It highlights a strong near and mid-term sentiment, a mid-channel oscillation, and an exceptional risk-reward setup targeting a 43.2% gain. The piece outlines three distinct trading strategies (Position, Momentum Breakout, Risk Hedging) and multi-timeframe signal analysis to optimize position sizing and manage risk.
2026-04-04 17:09:13
This article provides an earnings analysis and prediction for NUTX, detailing past performance, future forecasts, and investor considerations. It highlights recent earnings figures, including revenue and EPS, along with analyst estimates for upcoming quarters. The report also examines the correlation between earnings revisions and stock price movements, offering insights into potential trading strategies.
2026-04-04 15:09:53
This article highlights three promising small-cap companies in the US market: Euroseas (ESEA), Nutex Health (NUTX), and Caledonia Mining (CMCL). Each company is analyzed for its financial health, growth potential, and operational efficiency, aiming to offer investors opportunities beyond larger corporations. The US market has seen significant growth, making small caps attractive for investors seeking high-growth prospects.
2026-03-31 21:40:17
Nutex Health Inc (NUTX) is not recommended for beginner, long-term investors due to weak financial performance, including significant declines in revenue, net income, EPS, and gross margin in Q4 2025. Technical indicators show a bearish trend, with no strong buy signals or positive catalysts. Analyst ratings indicate a "Moderate Buy" overall, but with a recent price target downgrade from Maxim reflecting potential headwinds from accounting restatements and legal issues.
2026-03-25 01:10:00
This article analyzes Nutex Health Inc. (NASDAQ: NUTX) using AI models, highlighting divergent sentiment across time horizons and suggesting choppy conditions. It identifies an exceptional risk-reward setup targeting a 43.5% gain and provides specific institutional trading strategies (Position, Momentum Breakout, Risk Hedging) with detailed entry, target, and stop-loss levels. The analysis also includes multi-timeframe signal strengths, support, and resistance levels for the stock.
